MSFS
GILD icon

Main Street Financial Solutions’s Gilead Sciences GILD Stock Holding History

Main Street Financial Solutions’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$275K Sell
2,242
-1,023
-31% -$124K 0.02% 444
2025
Q3 		$362K Buy
+3,265
New +$371K 0.02% 459

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Main Street Financial Solutions's GILD Position: Q4 2025 in Review

Main Street Financial Solutions reduced its Gilead Sciences (GILD) stake by 31% in Q4 2025, selling an estimated $124K and leaving 2,242 shares worth $275K. The position accounts for 0.02% of the portfolio, ranked #444.

Main Street Financial Solutions first reported a position in GILD in Q3 2025 and has held it in 2 quarters since. The position peaked at $362K in Q3 2025. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Main Street Financial Solutions held 2,242 shares of Gilead Sciences worth $275K as of Q4 2025.
  • Main Street Financial Solutions sold 1,023 Gilead Sciences shares in Q4 2025, an estimated $124K.
  • Gilead Sciences made up 0.02% of Main Street Financial Solutions's portfolio in Q4 2025, its #444 holding.
  • Main Street Financial Solutions first reported a position in Gilead Sciences in Q3 2025 and has held it in 2 quarters since.
  • Main Street Financial Solutions's Gilead Sciences position peaked at $362K in Q3 2025.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Main Street Financial Solutions's 13F filing for Q4 2025, filed 17 Feb 2026.